Bicycle Therapeutics plc BCYC
$ 14.72
-1.87%
Quarterly report 2024-Q3
added 10-31-2024
Bicycle Therapeutics plc Financial Ratios 2011-2024 | BCYC
Annual Financial Ratios Bicycle Therapeutics plc
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.4 | -6.0 | -18.3 | -10.1 | -4.0 | - | - | - | - | - | - | - | - |
P/S |
29.7 | 47.0 | 104.6 | 49.4 | 8.8 | - | - | - | - | - | - | - | - |
EPS |
-5.1 | -3.8 | -2.7 | -2.7 | -2.8 | -49.8 | -48.8 | - | - | - | - | - | - |
EV (Enterprise Value) |
500 M | 480 M | 919 M | 443 M | 138 M | 88.1 M | 53.5 M | - | - | - | - | - | - |
EBITDA per Share |
-5.15 | -3.81 | -2.56 | -2.65 | -2.29 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-14.0 | -7.9 | -1.2 | - | - | - | - | - | - | - | - | ||
PEG |
- | 0.15 | 0.09 | - | - | - | - | - | - | - | - | ||
P/B |
2.2 | 2.5 | 3.5 | 5.4 | 1.3 | - | - | - | - | - | - | - | - |
P/CF |
-13.2 | -7.9 | -82.7 | -28.9 | -4.0 | - | - | - | - | - | - | - | - |
ROE % |
-48.71 | -41.63 | -19.30 | -53.44 | -32.84 | - | - | - | - | - | - | - | - |
ROA % |
-30.35 | -27.45 | -13.93 | -31.65 | -27.78 | - | - | - | - | - | - | - | - |
ROCE % |
-51.21 | -43.08 | -18.95 | -54.43 | -25.94 | - | - | - | - | - | - | - | - |
Current Ratio |
2.7 | 2.9 | 3.6 | 2.5 | 11.8 | - | - | - | - | - | - | - | - |
DSO |
- | 38.4 | 100.7 | 99.4 | 189.0 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 38.4 | 100.7 | 99.4 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 38.4 | 100.7 | 99.4 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Bicycle Therapeutics plc
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.74 | -0.77 | -0.62 | - | -1.26 | -1.41 | -1.3 | - | -0.96 | -0.9 | -0.93 | - | -0.59 | -0.74 | -0.73 | -0.83 | -0.52 | -0.67 | -0.63 | -0.25 | -0.53 | -1.4 | -7.8 | -13.19 | -17.73 | -11.85 | -6.38 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.89 | -0.87 | -0.71 | - | -1.24 | -1.37 | -1.34 | - | -0.96 | -0.9 | -0.91 | - | -0.53 | -0.71 | -0.71 | - | -0.5 | -0.66 | -0.63 | - | -0.53 | -1.03 | -3.69 | - | -13.4 | -11 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-30.12 | -36.00 | -50.81 | -47.42 | -57.21 | -55.01 | -44.27 | -26.75 | -35.35 | -34.15 | -38.14 | -32.60 | -50.86 | -52.89 | -52.97 | -53.44 | -39.90 | -39.46 | -37.73 | -32.84 | -18.60 | 2.59 | 20.68 | 32.97 | 23.46 | 12.45 | 5.32 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-21.53 | -24.25 | -29.86 | -26.30 | -33.10 | -32.08 | -28.70 | -18.79 | -24.01 | -16.43 | -24.36 | -20.37 | -31.19 | -32.27 | -31.86 | -31.65 | -24.83 | -27.15 | -28.90 | -27.78 | -31.91 | -32.73 | -29.56 | -23.66 | -15.52 | -6.10 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-34.14 | -38.67 | -52.92 | -48.99 | -59.27 | -57.34 | -46.52 | -27.34 | -35.71 | -33.79 | -37.19 | -31.81 | -42.99 | -45.81 | -46.82 | -36.56 | -47.56 | -47.38 | -42.77 | -23.11 | -14.00 | 6.10 | 21.77 | 16.20 | 16.20 | 7.10 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
6.0 | 5.8 | 2.9 | 2.6 | 2.9 | 1.9 | 2.3 | 2.9 | 3.3 | - | 3.5 | 3.6 | 2.5 | 2.7 | 2.7 | 2.5 | 2.5 | 2.5 | 2.5 | 6.5 | 6.5 | 6.5 | 6.5 | 2.8 | 2.8 | 2.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | 380.7 | 485.0 | - | - | - | 11.8 | - | - | 51.1 | 188.2 | 129.4 | 129.6 | 316.9 | 228.6 | 3.5 | 29.9 | 12.1 | 37.3 | 433.5 | 284.6 | 137.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | 380.7 | 485.0 | - | - | - | 11.8 | - | - | 51.1 | 188.2 | 129.4 | 129.6 | 316.9 | 228.6 | 3.5 | 29.9 | 12.1 | 37.3 | 433.5 | 284.6 | 137.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | 380.7 | 485.0 | - | - | - | 11.8 | - | - | 51.1 | 188.2 | 129.4 | 129.6 | 316.9 | 228.6 | 3.5 | 29.9 | 12.1 | 37.3 | 433.5 | 284.6 | 137.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency